From its 32,000-square-foot facility in Westminster, WES Pharma Inc develops and manufactures technology-driven specialty generic drugs for U.S. markets, spanning both prescription and over-the-counter products. The privately owned company takes products from in-house research and formulation through FDA approval and manufacturing, with particular focus on technically difficult, niche medicines. Its scientific team works across solid and liquid dosage forms, including products facing solubility, stability, and complex bioequivalence challenges.
Current Good Manufacturing Practices (cGMP)
compliance_program
ICH Guidelines
compliance_program